There is an error in the Correction published on April 20, 2017. The correct affiliation for the eighth author, Alberto Bartelli, is Candiolo Cancer Institute-FPO, IRCCS, Candiolo, TO, Italy and Department of Oncology, University of Torino, Candiolo, TO 10060, Italy.
References
- 1.Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, Marinari E, et al. (2016) CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours. PLoS ONE 11(2): e0149099 10.1371/journal.pone.0149099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Costa-Cabral S, Brough R, Konde A, Aarts M, Campbell J, Marinari E, et al. (2017) Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours. PLoS ONE 12(4): e0176578 10.1371/journal.pone.0176578 [DOI] [PMC free article] [PubMed] [Google Scholar]